Role of endothelins in animal models of hypertension: focus on cardiovascular protection

被引:21
作者
Moreau, P
Schiffrin, E
机构
[1] Univ Montreal, Fac Pharm, Lab Vasc Pharmacol, Montreal, PQ H3C 3J7, Canada
[2] Clin Res Inst Montreal, Montreal, PQ H2W 1R7, Canada
关键词
endothelin; endothelin antagonists; hypertension; vascular remodeling; hypertrophy; target-organ damage;
D O I
10.1139/Y03-015
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Investigation of the regulation of vascular function by endothelium-derived factors has been a prominent topic of research in the field of hypertension during the last decade. Of the different endothelial factors, endothelins, which play and important role in vasodilatation-vasoconstriction balance, have been the subject of great interest and an impressive number of publications. This peptide, a very potent vasoconstrictor, triggers as well events involved in growth, proliferation, matrix production and local inflammation. In parallel, its role in hypertension has evolved from a simple vasoconstrictor to a central local regulator of vascular homeostasis contributing not only to the elevation of blood pressure, but also to the complications of hypertension. This review summarizes research on endothelins and its receptor antagonists in experimental hypertension, with special emphasis on vascular remodeling and target-organ protection.
引用
收藏
页码:511 / 521
页数:11
相关论文
共 123 条
[1]  
Ammarguellat F, 2001, CIRCULATION, V103, P319
[2]   ETA receptor blockade prevents increased tissue endothelin-1, vascular hypertrophy, and endothelial dysfunction in salt-sensitive hypertension [J].
Barton, M ;
d'Uscio, LV ;
Shaw, S ;
Meyer, P ;
Moreau, P ;
Lüscher, TF .
HYPERTENSION, 1998, 31 (01) :499-504
[3]  
BARTON M, 1997, HYPERTENSION, V30, P508
[4]   REMODELING OF CEREBRAL ARTERIOLES IN CHRONIC HYPERTENSION [J].
BAUMBACH, GL ;
HEISTAD, DD .
HYPERTENSION, 1989, 13 (06) :968-972
[5]   Modulation of cardiac natriuretic peptide gene expression following endothelin type A receptor blockade in renovascular hypertension [J].
Bianciotti, LG ;
de Bold, AJ .
CARDIOVASCULAR RESEARCH, 2001, 49 (04) :808-816
[6]   Early-onset but not late-onset endothelin-A-receptor blockade can modulate hypertension, cerebral edema, and proteinuria in stroke-prone hypertensive rats [J].
Blezer, ELA ;
Nicolay, K ;
Goldschmeding, R ;
Jansen, GH ;
Koomans, HA ;
Rabelink, TJ ;
Joles, JA .
HYPERTENSION, 1999, 33 (01) :137-144
[7]   Synergistic effects of AT1 and ETA receptor blockade in a transgenic, angiotensin II-dependent, rat model [J].
Bohlender, J ;
Gerbaulet, S ;
Krämer, J ;
Gross, M ;
Kirchengast, M ;
Dietz, R .
HYPERTENSION, 2000, 35 (04) :992-997
[8]   Preglomerular sudanophilia in L-NAME hypertensive rats - Involvement of endothelin [J].
Bouriquet, N ;
Dupont, M ;
Herizi, A ;
Mimran, A ;
Casellas, D .
HYPERTENSION, 1996, 27 (03) :382-391
[9]   EFFECTS OF PROTECTION FROM PRESSURE ON RESISTANCE ARTERY MORPHOLOGY AND REACTIVITY IN SPONTANEOUSLY HYPERTENSIVE AND WISTAR-KYOTO RATS [J].
BUND, SJ ;
WEST, KP ;
HEAGERTY, AM .
CIRCULATION RESEARCH, 1991, 68 (05) :1230-1240
[10]   Selective antagonism of the ETA receptor reduces neointimal hyperplasia after balloon-induced vascular injury in pigs [J].
Burke, SE ;
Lubbers, NL ;
Gagne, GD ;
Wessale, JL ;
Dayton, BD ;
Wegner, CD ;
Opgenorth, TJ .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1997, 30 (01) :33-41